Abstract
The role of transforming growth factor-beta (TGF-β) is dual, such that, it inhibits tumor development in initial stage and promotes metastasis in later stage. The present study is aimed to analyse the relevance of different types of TGF-β and their receptors on the overall survival (OS) and TGF-β driven gene expression in individuals with cervical cancer (CC) using ONCODB and GEPIA databases. The in-silico gene expression analysis showed, TGF-β1 and TGFβR2 are upregulated in cells infected with human papilloma virus (HPV)16, whereas, TGF-β2, TGFβR1 and TGFβR3 expression were downregulated. In HPV 18 infected cells, TGF-β1, TGF-β2 and TGFβR1 were downregulated, meanwhile, TGF-β3, TGFβR2 and TGFβR3 were upregulated. OS analysis of CC patients with different TGF-β expression revealed that, TGF-β1, TGF-β2, TGF-β3 and TGFβR2 were associated with reduced survival rate. Further, we identified four microRNAs (miRNAs) (hsa-miR-21-5p, hsa-miR-29b-3p, hsa-miR-101-3p and hsa-miR-130a-3p) interacted favorably with TGF-β in HPV 16 and 18 positive samples using MIENTURNET. This present review further emphasizes that, targeting TGF-β could be a novel and futuristic approach for CC management and therapeutics.
Keywords:
Cervical Cancer; Exosomes; TGF-β; TGF-β Receptors; miRNA.
Copyright © 2024 Elsevier B.V. All rights reserved.
MeSH terms
-
Biomarkers, Tumor* / genetics
-
Biomarkers, Tumor* / metabolism
-
Female
-
Gene Expression Regulation, Neoplastic*
-
Human papillomavirus 16 / genetics
-
Human papillomavirus 18 / genetics
-
Humans
-
MicroRNAs* / genetics
-
MicroRNAs* / metabolism
-
Papillomavirus Infections / genetics
-
Papillomavirus Infections / virology
-
Receptor, Transforming Growth Factor-beta Type I / genetics
-
Receptor, Transforming Growth Factor-beta Type I / metabolism
-
Receptor, Transforming Growth Factor-beta Type II / genetics
-
Receptor, Transforming Growth Factor-beta Type II / metabolism
-
Receptors, Transforming Growth Factor beta / genetics
-
Receptors, Transforming Growth Factor beta / metabolism
-
Transforming Growth Factor beta / genetics
-
Transforming Growth Factor beta / metabolism
-
Transforming Growth Factor beta1 / genetics
-
Transforming Growth Factor beta1 / metabolism
-
Transforming Growth Factor beta2 / genetics
-
Transforming Growth Factor beta2 / metabolism
-
Transforming Growth Factor beta3 / genetics
-
Transforming Growth Factor beta3 / metabolism
-
Uterine Cervical Neoplasms* / diagnosis
-
Uterine Cervical Neoplasms* / genetics
-
Uterine Cervical Neoplasms* / metabolism
-
Uterine Cervical Neoplasms* / pathology
Substances
-
MicroRNAs
-
Biomarkers, Tumor
-
Transforming Growth Factor beta2
-
Receptors, Transforming Growth Factor beta
-
Transforming Growth Factor beta
-
Transforming Growth Factor beta1
-
TGFBR2 protein, human
-
Receptor, Transforming Growth Factor-beta Type II
-
MIRN29a microRNA, human
-
MIRN21 microRNA, human
-
Receptor, Transforming Growth Factor-beta Type I
-
TGFB1 protein, human
-
TGFB2 protein, human
-
Transforming Growth Factor beta3
-
TGFB3 protein, human